We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

HSBC Holdings plc isn’t the only 5%+ yielder I’d buy today

G A Chester discusses mighty dividend stock HSBC Holdings plc (LON:HSBA) and a small-cap high-yielder you may not have considered.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

HSBC (LSE: HSBA) is a true giant of the banking world. It ranks only behind Shell in the FTSE 100 and with a market cap of over £150bn, is bigger than Lloyds, Royal Bank of Scotland and Barclays combined. If I had to buy one Footsie bank and hold it forever, HSBC would be my pick.

The main reason I’d plump for HSBC is its geographic diversification, which is far more extensive than Barclays (over 80% of income from just the UK and US). And of course, UK-focused Lloyds and RBS. This diversification means it doesn’t have single-country risk. If one country is in a recession or depression, there are likely to be others elsewhere in the world that are thriving. This gives it a level of stability over the long term, while it also benefits from exposure to faster-growing emerging markets.

Should you buy HSBC Holdings shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Growth and income

Ten years on from the financial crisis, HSBC is now looking set for sustainable revenue growth and with operating costs projected to fall, for strong profit growth too. City analysts are forecasting earnings per share (EPS) of $0.60 for 2017 when it reports its results on 20 February, followed by 17% growth to $0.70 for 2018. This supports expected dividends of $0.51 and $0.52.

At a share price of 760p the forward price-to-earnings (P/E) ratio is 15, which looks undemanding in view of the forecast 17% earnings growth, while a 5% dividend yield only adds to the appeal. As such, HSBC is not only my top Footsie banking pick for its geographical diversification and long-term growth and income prospects, but also a stock I’d buy today due to what I see as its attractive valuation.

Bargain basement rating

Performance materials specialist Low & Bonar (LSE: LWB) may be a far smaller company than HSBC but, like the banking colossus, it has wide geographic diversification. Only Germany (17%) contributes more than 10% to group revenue and the UK contributes less than 5%. Also like HSBC, its profits are rising and its dividend yield is high.

The company today released results for its financial year ended 30 November. The shares are up 11% to 60p, valuing the business at around £200m. Revenue of £446m (up 12% on last year) and underlying EPS of 6.42p (up 7% thanks to favourable exchange rates) both came in slightly ahead of forecasts. The P/E is in the bargain basement at 9.3, while a 3.05p dividend gives a running yield of 5.1%.

Why such a cheap valuation?

Performance was mixed from Low & Bonar’s four divisions and included a hefty crash in profit from one of them and some under-performance within parts of another. One-off non-cash impairments actually pushed the group into a loss on a statutory basis. However, the company, which also announced the appointment of a new permanent chief executive today, laid out the problem areas and its strategy to remedy them with admirable transparency and detail.

The overhaul will be quite extensive but the plan, which includes reducing relatively high net debt of £138m by at least £15m this year, looks eminently credible. With management also having maintained the dividend as a reflection of its confidence, I see Low & Bonar as an attractive value play and on this basis I rate the stock a ‘buy’.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Barclays, HSBC Holdings, Lloyds Banking Group, and Royal Dutch Shell B. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »